MSR1 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P21757 |
---|---|
Clone Names | 100430276 |
Gene ID | 4481 |
---|---|
Other Names | Macrophage scavenger receptor types I and II, Macrophage acetylated LDL receptor I and II, Scavenger receptor class A member 1, CD204, MSR1, SCARA1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MSR1 |
---|---|
Synonyms | SCARA1 |
Function | Membrane glycoproteins implicated in the pathologic deposition of cholesterol in arterial walls during atherogenesis. Two types of receptor subunits exist. These receptors mediate the endocytosis of a diverse group of macromolecules, including modified low density lipoproteins (LDL) (PubMed:2251254). Isoform III does not internalize acetylated LDL (PubMed:9548586). |
Cellular Location | Membrane; Single-pass type II membrane protein. |
Tissue Location | Isoform I, isoform II and isoform III are expressed in monocyte-derived macrophages. Isoform I and isoform II are expressed in the liver, placenta and brain. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes the class A macrophage scavengerreceptors, which include three different types (1, 2, 3) generatedby alternative splicing of this gene. These receptors or isoformsare macrophage-specific trimeric integral membrane glycoproteinsand have been implicated in many macrophage-associatedphysiological and pathological processes including atherosclerosis,Alzheimer's disease, and host defense. The isoforms type 1 and type2 are functional receptors and are able to mediate the endocytosisof modified low density lipoproteins (LDLs). The isoform type 3does not internalize modified LDL (acetyl-LDL) despite having thedomain shown to mediate this function in the types 1 and 2isoforms. It has an altered intracellular processing and is trappedwithin the endoplasmic reticulum, making it unable to performendocytosis. The isoform type 3 can inhibit the function ofisoforms type 1 and type 2 when co-expressed, indicating a dominantnegative effect and suggesting a mechanism for regulation ofscavenger receptor activity in macrophages.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Wang, Y., et al. J. Hum. Genet. 55(8):490-494(2010)Voruganti, V.S., et al. Am. J. Clin. Nutr. 91(6):1574-1583(2010)Nonomura, N., et al. Cancer Sci. 101(6):1570-1573(2010)Seizer, P., et al. Semin. Thromb. Hemost. 36(2):157-162(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.